The effect of primary diseases is substantial, demanding fresh therapeutic modalities. Cellular therapies represent a especially promising avenue, offering the chance to restore damaged liver tissue and improve clinical outcomes. Currently, research focuses on several methods, including the introduction of induced pluripotent cellular entities dire